A recent british study showed that prescription of oral glucocorticoids are gradually decreasing, thanks in particular to the use of biologics. This is especially true for long-term prescriptions in patients with severe asthma, Crohn’s disease and ulcerative colitis. On the other hand, prescriptions continue do increase for patients suffering from chronic obstructive bronchitis (COPD). Asthma and COPD remain the most common diseases among people prescribed oral glucocorticoids.